Genus Plc engages in the provision of genetic livestock services to produce meat and milk. The company is headquartered in Basingstoke, Hampshire and currently employs 3,170 full-time employees. The company went IPO on 2000-07-06. The firm is advancing animal breeding and genetic improvement by applying biotechnology and selling added value products to livestock farming and food producers. The company focuses on the dairy, beef and pork food production sectors, through two businesses: ABS (bovine genetics) and PIC (porcine genetics). Its segments include Genus PIC, Genus ABS and Genus Research and Development. Its bovine genetics business sells dairy and beef bull semen and embryos from its superior cattle, which are sold to farmers to breed their cows through artificial insemination. Its porcine genetics business sells genetically superior breeding pigs and semen to farmers, so they can breed commercial pigs with desirable characteristics for pork production. Its porcine and bovine divisions operate under the brand names PIC and ABS. The company operates in 30 countries, across six continents, and reaches a further 50 markets through distribution partners.
Mr. Jorgen Kokke est le Chief Executive Officer de Genus plc, il a rejoint l'entreprise depuis 2023.
Quelle est la performance du prix de l'action GENUS UNSPON ADR EA REPR 1 ORD ?
Le prix actuel de GENUS UNSPON ADR EA REPR 1 ORD est de $37.84, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Genus plc ?
Genus plc appartient à l'industrie Biotechnology et le secteur est Health Care
Quel est la capitalisation boursière de Genus plc ?
La capitalisation boursière actuelle de Genus plc est de $2.5B
Est-ce que Genus plc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 12 analystes ont établi des notations d'analystes pour Genus plc, y compris 7 achat fort, 7 achat, 2 maintien, 0 vente et 7 vente forte